Executive Director Market Access Pipeline
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
The Executive Director of Global Market Access for Pipeline Assets will be responsible for shaping and implementing market access strategies for CSL Behring and CSL Vifor's pipeline assets. This high-impact role is accountable for driving pricing and reimbursement (P&R) readiness at each R&D stage gate decision-making point. It requires strong expertise in Health Economics, R&D interfaces, and a deep understanding of the payer environment in both the US and key international markets. In this role, the Executive Director will lead the Market Access pipeline team across all Therapeutic Areas (TAs) within CSL Behring and CSL Vifor. The position involves building, mentoring, and leading a high-performing global market access pipeline team, fostering a culture of collaboration, innovation, inclusion, and accountability. As a key member of the global Market Access Leadership Team (MALT), the Executive Director will contribute to the development and execution of functional strategy, operations, and capability building. The Executive Director will be accountable for Market Access deliverables at each R&D stage gate, continuously refining and improving standards for these deliverables. Collaboration with R&D, Regulatory Affairs, Medical Affairs, Marketing, and other partner functions is essential to influence clinical development programs, ensuring that market access considerations are integrated early in the product lifecycle. The role also involves analyzing and interpreting the payer landscape, payer policy trends, and economic data in both the US and key international markets to inform strategic decision-making for pipeline assets. Conducting Early Direct Scientific Advice with US payers and key international Pricing & Reimbursement (P&R) and Health Technology Assessment (HTA) agencies is crucial to secure input on clinical trial design and evidence generation, optimizing product profiles for market entry. The Executive Director will identify market access opportunities and risks, capturing opportunities and mitigating risks through proactive planning, scenario analysis, and stakeholder engagement. Developing Market Access Plans (MAP) for early and late-stage development assets is a key responsibility, aimed at maximizing asset lifecycle value while being responsible for patient access and public health. The MAP will be updated at each stage gate and major data readout. The Executive Director will also identify payer value drivers, define payer evidence requirements, and craft compelling payer value propositions (PVPs) and health economic models that demonstrate the clinical and economic value of pipeline assets to payers and other value stakeholders. Additionally, the role involves shaping Target Product Profiles (TPPs), clinical trial designs, and Target Product Claims (TPCs) to align with payer value drivers and evidence requirements. Proactively defining payer evidence requirements and evidence generation strategies, including real-world evidence (RWE), is essential, as is collaborating with the HEOR Shared Service to ensure high-quality, timely payer evidence generation and dissemination. The Executive Director will deliver early Global Value Dossiers (GVDs) and provide Market Access estimates for Business Development & Licensing (BD&L) assets.
